We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-2.67%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.59B
AUM Growth
-$234M
Cap. Flow
-$159M
Cap. Flow %
-6.14%
Top 10 Hldgs %
45.98%
Holding
325
New
10
Increased
161
Reduced
104
Closed
15
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBR icon
201
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$551K 0.02%
3,454
+13
+0.4% +$2.17K
HDSN
202
Hudson Technologies
HDSN
$254M
$547K 0.02%
41,163
AMP icon
203
Ameriprise Financial
AMP
$48.3B
$538K 0.02%
1,632
+12
+0.7% +$4.09K
BCRX icon
204
BioCryst Pharmaceuticals
BCRX
$2.28B
$521K 0.02%
73,575
+903
+1% +$6.49K
SCHM icon
205
Schwab US Mid-Cap ETF
SCHM
$14.5B
$505K 0.02%
22,368
-210
-0.9% -$4.97K
VRIG icon
206
Invesco Variable Rate Investment Grade ETF
VRIG
$1.8B
$501K 0.02%
20,098
+55
+0.3% +$1.37K
T icon
207
AT&T
T
$159B
$496K 0.02%
33,002
+198
+0.6% +$2.9K
OEF icon
208
iShares S&P 100 ETF
OEF
$20.1B
$496K 0.02%
2,470
AFL icon
209
Aflac
AFL
$64.9B
$493K 0.02%
6,430
+9
+0.1% +$668
SHEL icon
210
Shell
SHEL
$254B
$490K 0.02%
7,604
+12
+0.2% +$747
ES icon
211
Eversource Energy
ES
$26.9B
$479K 0.02%
8,231
+1,141
+16% +$76.1K
MFC icon
212
Manulife Financial
MFC
$73.9B
$459K 0.02%
25,103
-449
-2% -$8.49K
GPC icon
213
Genuine Parts
GPC
$17.1B
$447K 0.02%
3,099
ED icon
214
Consolidated Edison
ED
$40.1B
$446K 0.02%
5,218
+4
+0.1% +$364
BSX icon
215
Boston Scientific
BSX
$69.5B
$428K 0.02%
8,101
-1
-0% -$52
OTIS icon
216
Otis Worldwide
OTIS
$27.4B
$422K 0.02%
5,249
+23
+0.4% +$1.97K
SPGP icon
217
Invesco S&P 500 GARP ETF
SPGP
$2.25B
$415K 0.02%
4,545
-1,945
-30% -$181K
D icon
218
Dominion Energy
D
$60.8B
$399K 0.02%
8,923
+86
+1% +$4.27K
AZN icon
219
AstraZeneca
AZN
$263B
$391K 0.02%
2,889
+25
+0.9% +$3.42K
CB icon
220
Chubb
CB
$135B
$388K 0.02%
1,864
-67
-3% -$13.5K
TRV icon
221
Travelers Companies
TRV
$78.1B
$387K 0.01%
2,367
+6
+0.3% +$1K
IRWD icon
222
Ironwood Pharmaceuticals
IRWD
$696M
$386K 0.01%
40,051
MCHP icon
223
Microchip Technology
MCHP
$40.3B
$371K 0.01%
4,757
+28
+0.6% +$2.34K
ALE
224
DELISTED
Allete
ALE
$367K 0.01%
6,951
+84
+1% +$4.73K
YUM icon
225
Yum! Brands
YUM
$41.8B
$356K 0.01%
2,851
+20
+0.7% +$2.63K

Similar funds

Grimes & Company's Q3 2023 Portfolio in Review

As of Q3 2023, Grimes & Company held 325 positions worth $2.59B, down 8.3% from $2.82B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Grimes & Company withdrew a net $159M in Q3 2023, closing 15 positions and reducing 104 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $1.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grimes & Company opened a new position in DocuSign worth $12M.

  • Grimes & Company's largest Q3 2023 buy was DocuSign: 286,831 shares worth $12M.
  • Grimes & Company added most to State Street Technology Select Sector SPDR ETF in Q3 2023, an estimated $58.1M increase.
  • Grimes & Company's biggest Q3 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $82.8M.
  • Grimes & Company fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q3 2023, selling an estimated $1.9M.
  • Grimes & Company's ten largest holdings make up 46% of its $2.59B portfolio in Q3 2023.
  • Grimes & Company opened 10 new positions and closed 15 in Q3 2023.
  • Grimes & Company's portfolio value fell 8.3% quarter-over-quarter to $2.59B.

Based on Grimes & Company's 13F filing for Q3 2023, filed 19 Oct 2023.